Cargando…
Understanding the pathophysiology of NOMID arthropathy for drug discovery by iPSCs technology
Autores principales: | Nakagawa, K, Okuno, Y, Nishikomori, R, Yokoyama, K, Tanaka, T, Kawai, T, Yasumi, T, Umeda, K, Nakayama, N, Toguchida, J, Hagiwara, M, Heike, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599947/ http://dx.doi.org/10.1186/1546-0096-13-S1-P195 |
Ejemplares similares
-
PW02-029 - Single cell fluorescent immunoassay of CINCA/NOMID
por: Nakagawa, K, et al.
Publicado: (2013) -
Diagnosis of NLRP3 somatic mosaicism in CINCA/NOMID patients using next-generation sequencing
por: Izawa, K, et al.
Publicado: (2011) -
Effect of anakinra on arthropathy in CINCA/NOMID syndrome
por: Miyamae, Takako, et al.
Publicado: (2010) -
Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias
por: Pretemer, Yann, et al.
Publicado: (2021) -
Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
por: Maekawa, Hirotsugu, et al.
Publicado: (2022)